| Wed, Nov 26, 2008 | | • | INTROGEN THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Wed, Nov 26)
| | • | Introgen Restructures Operations to Focus on Revenue-Generating Manufacturing Capabilities
Business Wire (Wed, Nov 26)
| | Fri, Nov 21, 2008 | | • | INTROGEN THERAPEUTICS INC Financials
EDGAR Online Financials (Fri, Nov 21)
| | Tue, Nov 18, 2008 | | • | Introgen Announces the Transfer of its Listing of Common Stock from the Nasdaq Global Market to the Nasdaq Capital Market
Business Wire (Tue, Nov 18)
| | • | INTROGEN THERAPEUTICS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or S
EDGAR Online (Tue, Nov 18)
| | Wed, Nov 12, 2008 | | • | New Star Analyst Rankings for Introgen Therapeutics, Inc.
StarMine (Wed, Nov 12)
| | • | INTROGEN THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Wed, Nov 12)
| | Tue, Nov 11, 2008 | | • | Introgen Therapeutics Reports Third Quarter 2008 Financial Results
Business Wire (Tue, Nov 11)
| | Mon, Oct 27, 2008 | | • | Biotech Stock-Picking: Incyte, Celgene
at TheStreet.com (Mon, Oct 27)
| | Fri, Oct 24, 2008 | | • | Dell, Whole Foods among local stocks trading at 52-week lows as Wall St. falls
at bizjournals.com (Fri, Oct 24)
| | Wed, Oct 22, 2008 | | • | Illuminating Illumina
at Motley Fool (Wed, Oct 22)
| | Fri, Oct 17, 2008 | | • | [$$] Genentech Study Good News for ImmunoGen
at RealMoney by TheStreet.com (Fri, Oct 17)
| | Mon, Oct 6, 2008 | | • | Introgen gets second notice from Nasdaq, says it will fight removal from exchange
at bizjournals.com (Mon, Oct 6)
| | Fri, Oct 3, 2008 | | • | INTROGEN THERAPEUTICS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or S
EDGAR Online (Fri, Oct 3)
| | • | Introgen Receives Notification from Nasdaq
Business Wire (Fri, Oct 3)
| | Fri, Sep 5, 2008 | | • | INTROGEN THERAPEUTICS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or S
EDGAR Online (Fri, Sep 5)
| | • | Introgen Receives Staff Determination Letter from Nasdaq Global Market
Business Wire (Fri, Sep 5)
| | • | [$$] Biotech Mailbag: Epix Pharmaceuticals
at RealMoney by TheStreet.com (Fri, Sep 5)
| | Thu, Sep 4, 2008 | | • | Introgen sell-off continues
at bizjournals.com (Thu, Sep 4)
| | Tue, Sep 2, 2008 | | • | Health Winners & Losers: Sciele Pharma
TheStreet.com (Tue, Sep 2)
|
Add INGN News to My Yahoo!:
 
| |
|
4.48% Nasdaq 
Headlines
